On March 30, 2026, IGC Pharma, Inc. (NYSE American: IGC), a clinical-stage biotechnology company focused on developing therapeutics for Alzheimer’s disease, announced a significant strategic partnership with FMW Media Works LLC, known for its financial media platform, New to The Street. This collaboration aims to enhance the visibility of IGC Pharma among both institutional and retail investors through a comprehensive media strategy. The partnership will feature a 12-part national media campaign that includes long-form televised interviews, national television commercial distribution, and digital amplification, reaching a combined audience of over 4.45 million YouTube subscribers. Additionally, the campaign will utilize high-visibility outdoor placements in key financial markets, including Times Square and the New York City Financial District. IGC Pharma believes that this initiative will not only increase market awareness but also support its ongoing commitment to disciplined clinical execution and scientific development. The company’s lead asset, IGC-AD1, is currently in a Phase 2 trial for agitation in Alzheimer’s dementia, and the partnership is expected to bolster investor confidence and engagement as the company progresses in its clinical endeavors.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.